Form 8-K - Current report:
SEC Accession No. 0001140361-25-005012
Filing Date
2025-02-18
Accepted
2025-02-18 16:35:31
Documents
14
Period of Report
2025-02-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K ef20043809_8k.htm   iXBRL 8-K 31516
  Complete submission text file 0001140361-25-005012.txt   216925

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bmy-20250214.xsd EX-101.SCH 4813
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bmy-20250214_def.xml EX-101.DEF 18374
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmy-20250214_lab.xml EX-101.LAB 27789
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmy-20250214_pre.xml EX-101.PRE 20673
16 EXTRACTED XBRL INSTANCE DOCUMENT ef20043809_8k_htm.xml XML 8285
Mailing Address ROUTE 206 AND PROVINCE LINE ROAD PRINCETON NJ 08543
Business Address ROUTE 206 AND PROVINCE LINE ROAD PRINCETON NJ 08543 6092524621
BRISTOL MYERS SQUIBB CO (Filer) CIK: 0000014272 (see all company filings)

EIN.: 220790350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-01136 | Film No.: 25635596
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)